Abstract:Background/Aims: Epithelial cells line the intestinal mucosa and form an important barrier for maintaining host health. This study aimed to explore the mechanism of the Sphingosine-1-phosphate (S1P)/Sphingosine-1-phosphate receptor 2 (S1PR2) pathway in intestinal epithelial cells (IECs) that participate in the intestinal barrier function. Methods: In this study, we constructed a knockout of the S1PR2 gene in mice, and Dextra sulfate sodium (DSS) was used to induce colitis. We isolated IECs from wild type (WT) and S1PR2–/– mice, and the endogenous expression of S1PR2 and Zonula occludens 1 (ZO-1) in IEC were detected by Western blot. Next, the major histocompatibility complex II (MHC-II) expression was analyzed by reverse transcription quantitative real-time (RT-qPCR) and flow cytometry. The in vivo and in vitro intestinal permeability were evaluated by serum fluorescein isothiocyanate (FITC) concentration. The tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interferon-γ (IFN-γ) levels in cell suspension were analyzed by enzyme-linked immuno sorbent assay (ELISA). A carboxyfluorescein diacetate succinimidyl ester (CFSE) assay was used to detect the T-cell proliferation in a co-culture system. Results: The intestinal mucosal barrier damage in S1PR2–/– mice was more severe than in the WT mice, and there were more CD4+T-cells in the colon tissue of DSS-treated S1PR2–/– mice. Either the mouse colon carcinoma cell line (CT26. WT) or the IECs upregulated MHC-II expression, which then promoted CD4+T-cell proliferation. The S1P/S1PR2 pathway controlled MHC-II expression to regulate CD4+T-cell proliferation via the extracellular signal-regulated kinase (ERK) pathway. In addition, the IFN-γ that was secreted by CD4+T-cells increased DSS-induced damage of intestinal epithelial cell barrier function. ZO-1 expression was increased by S1P in CT26.WT cells, while S1PR2 antagonist JTE-013 expression was downregulated. However, in CT26.WTsi-S1PR2 cells, S1P had no effect on ZO-1 expression. Conclusions: The S1P/S1PR2 axis in IECs mediated CD4+T-cell activation via the ERK pathway and MHC-II expression to regulate intestinal barrier function.

miR-542-5p targets c-myc and negates the cell proliferation effect of SphK1 in intestinal epithelial cells

miR-495 promotes intestinal epithelial cell apoptosis through downregulation of Sphingosine-1-phosphate

MicroRNA-195 regulates Tuft cell function in the intestinal epithelium by altering translation of DCLK1

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2

The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells–CD4+T-Cell Interactions

MicroRNA-200 Loaded Lipid Nanoparticles Promote Intestinal Epithelium Regeneration in Canonical MicroRNA-Deficient Mice

The function of Sphingosine-1-phosphate receptor 2 (S1PR2) in maintaining intestinal barrier and inducing ulcerative colitis

MicroRNA 452 regulates SHC1 expression in human colorectal cancer and colitis

MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling

miR-153-3p Attenuates the Development of Gastric Cancer by Suppressing SphK2

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability

Inhibition of miR-142-3p promotes intestinal epithelial proliferation and barrier function after ischemia/reperfusion injury by targeting FoxM1

Microrna-21 Represses Human Cystathionine Gamma-Lyase Expression By Targeting At Specificity Protein-1 In Smooth Muscle Cells

Circ_0000370 Plays an Oncogenic Role in Colorectal Cancer by Regulating the Mir-502-5p/sirt1 Axis.

MiR-509-3-5p Causes Aberrant Mitosis and Anti-Proliferative Effect by Suppression of PLK1 in Human Lung Cancer A549 Cells

Hsa-Mirna-26b Regulates Spak Expression During Intestinal Epithelial Cell Differentiation

C-Myc-Regulated Mirna-92b Inhibits Expression of the E3 Ligase Fbxw7 in Colorectal Cancer

MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

MiR-34a-5p suppresses cutaneous squamous cell carcinoma progression by targeting SIRT6